1481-92-1Relevant articles and documents
-
Karrer,Banerjea
, p. 1692 (1949)
-
A ring size-selective reduction of lactones using SmI2 and H2O
Duffy, Lorna A.,Matsubara, Hiroshi,Procter, David J.
, p. 1136 - 1137 (2008)
The SmI2-H2O reducing system shows complete selectivity for six-membered lactones over other classes of lactone and esters. Experimental and computational studies suggest that the origin of the selectivity lies in the initial electro
COMPOUNDS AND COMPOSITIONS FOR OCULAR DELIVERY
-
Page/Page column 108; 217, (2020/05/12)
The present invention provides new prodrags of Sunitinib, Brinzolamide, and Dorzolamide and compositions to treat medical disorders, for example glaucoma, a disorder or abnormality related to an increase in intraocular pressure (TOP), a disorder requiring neuroprotection, age-related macular degeneration, or diabetic retinopathy.
Design, Synthesis, and Cellular Uptake of Oligonucleotides Bearing Glutathione-Labile Protecting Groups
Saneyoshi, Hisao,Ohta, Takayuki,Hiyoshi, Yuki,Saneyoshi, Takeo,Ono, Akira
supporting information, p. 862 - 866 (2019/02/14)
Glutathione-labile protecting groups for phosphodiester moieties in oligonucleotides were designed, synthesized, and incorporated into oligonucleotides. The protecting groups on the phosphodiester moieties were cleaved in a buffer containing 10 mM glutath